Zynerba

Harmony Makes Rare Disease Play with Potential $200M Zynerba Buyout
BioSpace
Tue, 08/15/23 - 11:36 am
Harmony Biosciences
Zynerba
M&A
neuropsychiatric
Zynerba cites 'tripledemic' for PhIII delay of a cannabinoid drug that's failed multiple times
Endpoints
Wed, 12/21/22 - 12:43 pm
Zynerba
cannabinoids
Zynerba flunks another PhII trial, all but ending Fragile X hopes
Endpoints
Tue, 06/30/20 - 10:43 am
Zynerba
CBD
Fragile X syndrome
clinical trials
After failure, Zynerba shifts gears to save cash
Biopharma Dive
Thu, 07/5/18 - 08:26 pm
Zynerba
clinical trials
ZYN001
ZYN002
IPO Preview: Is Zynerba The Next GW Pharmaceuticals?
Seeking Alpha
Wed, 08/5/15 - 10:16 am
IPOs
Zynerba
GW Pharma